Statera Biopharma, Inc. Increase (Decrease) in Contract with Customer, Liability
Statera Biopharma, Inc. reported Increase (Decrease) in Contract with Customer, Liability of $13.46 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2022-11-14
- Statera Biopharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-12-31 was $0.00.
- Statera Biopharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2020-12-31 was $0.00.
- Statera Biopharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2021 was -$130.83K.
- Statera Biopharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2020 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|
| 2022-09-30 | $13.46K 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | -$130.83K 10-K · filed 2022-10-06 | |
| 2021-09-30 | -$130.83K 10-Q · filed 2022-11-14 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $0.00 10-K · filed 2022-10-06 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 |